Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Mr. Chemerinsky is the dean of the law school at the University of California, Berkeley. On Wednesday, the Trump administration sent letters to nine major universities proposing a “compact.” As The ...

Sony welcomed October 2025 with PS5 system software update 25.06-12.02.00 bright and early this morning. The update is rolling out worldwide now, and those who haven’t been prompted to update yet will ...

India’s food processing sector is set for a massive boost after the government signed agreements worth Rs 1.02 lakh crore with 26 domestic and global companies during the World Food India 2025 summit, ...

Scientists in China have developed a revolutionary new “bone glue” that can heal fractures, which could traditionally take months to heal, in a matter of minutes, according to a report. Product ...

KYOTO & FUJISAWA, Japan--(BUSINESS WIRE)--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

The 2025 Irish Open offered a $6 million purse, and Rory McIlroy claimed the top prize. Here's the full breakdown of payouts. Rory McIlroy won the Irish Open for the second time in his career. / ...

We’re celebrating 180 years of Scientific American. Explore our legacy of discovery and look ahead to the future. In 1957, just four years after Francis Crick and other scientists solved the riddle of ...

A new type of all-carbon molecule has been studied under normal room-temperature conditions. This marks only the second time this has ever been done, after spherical buckyballs were synthesised 35 ...

Superluminal to receive payments, equity investment, royalties Lilly, Novo pursuing GPCR-targeting drugs for obesity Superluminal's lead candidate not part of deal with Lilly Aug 14 (Reuters) - Eli ...

More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee to consider the asset’s potential approval in a rare disease, pushing the ...